Huminig, Ayisha .

HRN: 27-31-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
CEFUROXIME 750MG (VIAL)
11/25/2025
12/02/2025
IV
430 Mg
Q 8 Hours
UTI
Checking Final Appropriateness 
11/27/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2025
12/02/2025
ORAL
3.5ml
BID
URTI
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: